Citius Oncology reported cash from operations of -$2.71M and free cash flow of -$2.71M for the quarter ended Jun 2026. This cash flow statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Net Income | -0.15M | -0.20M | -0.77M | -4.73M | -9.56M | -14.34M | -6.66M | -7.74M | -5.37M | -5.00M | -5.53M | -26.61M | -8.92M | |
| Share-based Compensation | 12.60M | 1.92M | 3.87M | 5.83M | 12.75M | 18.50M | 18.50M | 18.17M | 2.30M | 18.10M | 18.10M | 18.10M | ||
| Deferred Taxes | 0.14M | 0.29M | 0.43M | 0.26M | 0.26M | 0.26M | 0.26M | 0.26M | -0.23M | -0.11M | ||||
| Cash from Operations | -0.17M | -0.10M | -0.38M | -0.19M | -0.37M | -7.35M | -3.83M | -2.71M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||
| Amortization of Deferred Charges | 0.18M | |||||||||||||
| Change in Working Capital | ||||||||||||||
| Change in Receivables | 4.05M | -2.97M | -0.39M | |||||||||||
| Change in Inventory | 6.11M | 0.96M | 1.87M | 3.71M | 0.35M | 0.02M | -0.03M | |||||||
| Change in Account Payables | -1.08M | 7.62M | 11.45M | 2.31M | 2.05M | 2.52M | 2.65M | -2.79M | -1.56M | -1.57M | ||||
| Change in Accured Expenses | 0.02M | 0.07M | 0.36M | -0.20M | -0.26M | 0.19M | 6.23M | 2.49M | -0.26M | -4.37M | 0.43M | 19.54M | 0.02M | |
| Investing Activities | ||||||||||||||
| Cash from Investing Activities | -0.66M | 24.74M | 0.07M | -4.40M | -0.60M | -2.00M | ||||||||
| Financing Activities | ||||||||||||||
| Other financing activities | 9.56M | |||||||||||||
| Debt Issuance and Repayment | ||||||||||||||
| Long-Term Debt Issuances | 0.78M | 0.20M | 0.33M | |||||||||||
| Change in Capital Stock | ||||||||||||||
| Net Shares Issued and Repurchased | 0.15M | 5.75M | 5.75M | |||||||||||
| Net Equity Issued and Repurchased | 15.17M | 15.13M | -0.06M | -818.00 | ||||||||||
| Misc. | ||||||||||||||
| Cash from Financing Activities | 0.78M | -24.55M | 0.26M | 15.13M | -0.23M | 18.64M | ||||||||
| Change in Cash | -0.17M | 0.25M | -0.26M | 584.00 | -0.03M | 3.37M | -4.66M | 13.93M | ||||||
| Free Cash Flow | -0.17M | -0.10M | -0.38M | -0.19M | -0.37M | -7.35M | -3.83M | -2.71M | ||||||
| Net Cash Flow | -0.17M | -0.10M | -0.26M | 584.00 | -0.03M | 3.37M | -4.66M | 13.93M |